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Background: Pomegranate (Punica granatum) fruits are commonly regarded as medicinal plant in Indonesia, and the 
polyphenols found in pomegranate juice (punicalagin and ellagic acid) have been shown to have antibacterial properties. 
Objectives: Using monospecies and multispecies biofilms, we sought to examine the effects of pomegranate juice on the 
viability of three periodontal pathogens: Porphyromonas gingivalis, Aggregatibacter actinomycetemcomitans, and 
Treponema denticola. Methods: Biofilm assays were performed using crystal violet. Pomegranate juice was obtained 
from pomegranates using a juicer, and the juice was then diluted into different concentrations with phosphate saline 
buffer. The three pathogens were cultured in both monospecies and multispecies plates. Pomegranate juice was then 
added to each biofilm well. These were then incubated for 1h, 6h, or 24h, after which the optical density (OD) of the 
biofilm mass was measured using a microplate-reader (490 nm). Biofilm without treatment was used as a negative control 
and 0.2% chlorhexidine gluconate as a positive control. Data were analyzed with a one-way ANOVA; the level of 
significance was set at p<0.05. Results: Compared to the negative control, biofilm mass was significantly decreased after 
treatment with pomegranate juice across all concentrations and incubation times, for both monospecies and multispecies 
biofilm (p<0.05). The best results were achieved with P. gingivalis biofilm, with 100% concentration (OD 0.34 ± 0.03); 
A. actinomycetemcomitans, 50% concentration (OD 0.22 ± 0.01); and T. denticola, with 25% concentration (OD 0.87 ± 
0.08), as well as with a multispecies biofilm with a 50% concentration in 1h incubation time (OD 0.09 ± 0.02). 
Conclusion: Pomegranate juice effectively inhibited the biofilm formation of P. gingivalis, A. actinomycetemcomitans, 
and T. denticola. Pomegranate juice may therefore be used as an alternative therapy in preventing periodontal disease. 
Additional research should explore this effect in an environment that mimics oral cavities. 
Keywords :   Aggregatibacter actinomycetemcomitans, biofilm, Punica granatum, pomegranate, Porphyromonas 
gingivalis, Treponema denticola 
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Dental caries and periodontal disease have become 
global health problems.1 The accumulation of dental 
biofilm, which is accompanied by a change in bacterial 
composition, can lead to the onset of dental diseases, such 
as dental caries, gingivitis, and periodontal disease.2 
Biofilm is defined as an aggregation of oriented 
microorganisms attached to each other or to a surface and 
covered in a self-generated extracellular polymeric 
substance. Bacterial colonization of the mouth begins from 
the bottom layer of dental biofilm; early colonists bind to 
the teeth through adhesion to dental pellicles, and later 
colonists bind to the previous colonies.3 Over 700 
bacterial species have been detected in oral cavities, 
including in dental biofilms.3 Their distribution is not 
random; most species prefer specific environments, such 
as the anaerobic conditions provided by periodontal 
pockets.4 The specific bacteria isolated in human dental 
biofilm consist primarily of anaerobic Gram-negative 
rods, such as Treponema denticola, Porphyromonas 
gingivalis, and Aggregatibacter actinomycetemcomitans; 
these are known to be involved in periodontal disease.5, 6 
Within the field of dentistry, chlorhexidine gluconate 
(CHX) is the most widely used antimicrobial agent and is 
widely considered to promote plaque reduction due to its 
effectiveness against oral pathogens.7 Nevertheless, the 
use of chlorhexidine remains controversial as it also stains 
the teeth and detrimental effects on vital tissues and lead 
to the development of hypersensitivity.8,9 The need 
therefore exists for the development of new agents that 
inhibit the growth of biofilm-forming bacteria, as one 
strategy to prevent oral diseases. 
The use of ―plant products‖—secondary metabolites 
produced by plants—as an alternative method for 
controlling pathogenic microorganisms has become 
popular in recent years.5,10,11,12,13 These substances 
commonly serve as plants‘ own defense mechanisms 
against microorganisms, insects, and herbivores.14 
Pomegranates (Punica granatum L.), which are widely 
grown in southern China, India, and Southeast Asia, are 
often used in traditional medicine, as well as for 
consumption and ornamentation.15 Pomegranates are rich 
in polyphenols, which possess anti-inflammatory, 
antioxidant, antibacterial, and anti-cancerous proper-
ties.11,16,17 Several fatty acids, sterols, triterpenes, 
anthocyanins, flavonoids, and tannins have been identified 
in pomegranates‘ pericarp juice, leaves, and seeds.18 
Previous research has suggested that pomegranate‘s 
anti-inflammatory effects may be beneficial in treating 
periodontal disease.19 One placebo-controlled study found 
that pomegranate juice decreased plaque formation and 
reduced periodontal pocket depth over a three-month 
period.14 However, research has not yet established 
whether pomegranate juice can eradicate dental biofilm 
formation. The present study was sought to evaluate the 
effects of pomegranate juice on the growth of both 
monospecies and multispecies oral bacteria that are known 
as periodontal pathogens. To this end, we examined the 
effects of pomegranate (Punica granatum L.) juice on the 
viability of P. gingivalis, A. actinomycetemcomitans, and 
T. denticola in both monospecies and multispecies 
bacterial cultures. We then compared the biofilm mass in 
each in vitro culture. 
Pomegranate juice was obtained using a juicer. The 
resultant juice was then filtered using a Whatman® filter 
no. 1 to remove the seeds, and was subsequently re-
filtered using a 0.22 μm Acrodisc® filter for sterilization. 
The sterile juice was then diluted into different 
concentrations (12.5%, 25%, 50%, 100%) using phosphate 
buffer saline (PBS, pH 7.3–7.5). 
P. gingivalis ATCC 33277T, A. actinomycetem-
comitans ATCC 33384T, and T. denticola ATCC 35405T 
were cultured in brain heart infusion (BHI) agar (Thermo 
Scientific, Waltham, MA, USA) at 37°C for 48 hours in 
anaerobic conditions (10% CO2, 10% H, 80% N2). They 
were then re-cultured in BHI broth for 48h at 37°C and 
were incubated in a GasPak jar system (Becton Dickinson, 
Franklin Lakes, NJ, USA). 
Biofilm assays were performed using crystal violet 
assays.  Samples of 200 µL, each containing  1×107 
CFU/mL  of  periodontal  pathogen  (either  P.   gingivalis, 
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A. actinomycetemcomitans, T. denticola, or a mixture of 
the three), were distributed into individual 96-well plates. 
The samples were incubated for 48h to form biofilms and 
were then washed using PBS. Subsequently, different 
concentrations (12.5%, 25%, 50%, 100%) of pomegranate 
juice were distributed into well plates that contained 
biofilms. These were incubated for 1h, 6h, or 24h. Biofilm 
samples without the addition of any juice served as 
negative controls. For the positive control, we applied 
0.2% CHX to biofilm samples. Results were compared by 
measuring the optical density (OD) of each sample‘s 
biofilm mass. OD was measured using a microplate reader 
(490 nm). All experiments were performed in triplicate. 
We used the Shapiro-Wilk test for normality and 
Levene‘s test to assess homogeneity of variance. Biofilm 
differences between the experimental groups were 
analyzed using a one-way ANOVA with Post-Hoc test. 
P<0.05 was considered statistically significant. Statistical 
calculations were performed using SPSS Statistics v.20 
software for Windows (IBM, USA). 
We found that, compared to the untreated negative 
control, biofilm mass was significantly decreased after 
treatment with pomegranate juice in all concentrations and 
all incubation times, across all monospecies and 
multispecies samples. The mean OD (±SD) of the negative 
controls were 1.31 (±0.11), 1.01 (±0.17), 1.97 (±0.16), and 
1.32 (±0.12) for P. gingivalis, A. actinomycetemcomitans, 
T. denticola, and the multispecies samples, respectively. 
As further shown in Fig. 1–4, P. gingivalis was maximally 
inhibited using concentration of 100% juice in 1h (OD 
0.34±0.03); A. actinomycetemcomitans was maximally 
inhibited using 50% juice in 1h (OD 0.22±0.01); T. 
denticola was maximally inhibited using 25% juice in 1h 
(OD 0.87±0.08); and the multispecies culture was 
maximally inhibited using 50% juice in 1h 
(OD 0.09±0.02). Moreover, a one-way ANOVA test 
showed that the biofilm decrease was significant (p<0.05) 
across all concentrations and incubation times.  
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Figure 1. The reduction of T. denticola biofilms (as measured by optical density) after application of 
pomegranate juice (12.5%, 25%, 50%, 100%), compared to negative and positive controls. Biofilm 
without treatment was used as a negative control and chlorhexidine gluconate (0.2%) as a positive 
control.  
103 
SCIENTIFIC DENTAL JOURNAL 03 (2018) 101-108 
00.2
0.4
0.6
0.8
1
1.2
1.4
1.6
Control (-) 12,5% 25% 50% 100% Control (+)
B
io
fi
lm
 M
a
ss
 (
O
p
ti
ca
l 
D
en
si
ty
) 
Concentrations of Punica granatum juice  
Porphyromonas gingivalis biofilms  
1 hour
6 hours
24 hours
Figure 2. The reduction of P. gingivalis biofilms (as measured by optical density) after application of 
pomegranate juice (12.5%, 25%, 50%, 100%), compared to negative and positive controls. Biofilm 
without treatment was used as a negative control and chlorhexidine gluconate (0.2%) as a positive 
control.  
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Figure 3. The reduction of A. actinomycetemcomitans biofilms (as measured by optical density) after 
application of pomegranate juice (12.5%, 25%, 50%, 100%), compared to negative and positive 
controls. Biofilm without treatment was used as a negative control and chlorhexidine gluconate 
(0.2%) as a positive control.  
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We found that pomegranate juice effectively 
inhibited periodontal pathogens biofilm formation. More 
specifically, our results indicated an inhibitory effect of 
pomegranate juice on biofilm formation in monospecies 
and multispecies P. gingivalis, A. actinomycetem-
comitans, and T. denticola cultures. In all samples, 
biofilm OD decreased after 1h of incubation with 
pomegranate juice. 
In the present study, pomegranate juice‘s 
antimicrobial effects were observed to gradually decline 
with longer incubation times. At 1-hour incubation, the 
formation of biofilm enters an adhesion stage, at which 
point its attachment is reversible and the attached bacteria 
can be easily detached from the pellicle layer.2 The 24h 
incubation period yielded the highest amount of bacterial 
biofilm because it allowed the biofilms to enter the 
maturation stage, at which point biofilm pathogens can 
increase their antibacterial resistance. Thicker biofilms 
make   it    more    difficult   for   antibacterial   agents   to 
 
penetrate into the biofilm,20 possibly due to the biofilm‘s 
glycocalyx matrix, which protects the microorganisms 
inside and thus increases their immunity to any 
antimicrobial and antibiotic agents.21 This could also be 
related to the presence of dormant persister cells; it is 
plausible that the bacterial populations in the biofilms 
might develop higher antimicrobial resistance during 
stationary phases as the persister cells synthesize 
glycocalyx matrixes to enhance their immune 
systems.22,23 It has been previously shown that at the end 
stage of antimicrobial activities from many antimicrobial 
agents, persisters can start to re-induce biofilm formation, 
thus further increasing their immunity.24 
A previous study tested the antimicrobial effects of 
pomegranate juice against several Gram-positive and 
Gram-negative bacteria and found that pomegranate juice 
effectively inhibited the growth of B. cereus, B. 
coagulans, B. subtilis, E. coli, K. pneumoniae, P. 
aeruginosa,  and  S. aureus.21  This likely occurred due to 
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Figure 4. The reduction of multispecies biofilms (as measured by optical density) after application of 
pomegranate juice (12.5%, 25%, 50%, 100%), compared to negative and positive controls. Biofilm 
without treatment was used as a negative control and chlorhexidine gluconate (0.2%) as a positive 
control.  
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pomegranate juice‘s previously demonstrated antibacterial 
activity. It possesses polyphenolic compounds which can 
affect bacterial cell walls, inhibit enzymes with oxidized 
agents, interact with proteins, and interfere with the co-
aggregation mechanism of microorganisms.25 However, 
other research has found that the antibacterial compounds 
of pomegranates are relative to the amount and 
concentration of the pomegranate juice used,26 and the 
minimum concentration of pomegranate juice needed to 
inhibit bacterial growth could vary depending on the 
method of extraction, type of solvents, and variety of 
bacterial strains used.21 Although fresh pomegranate juice 
typically consists of approximately 85.4% water and 
15.6% dry substances (including pectins, organic acids, 
hydrolyzing tannins, anthocyanins, and polyphenols), if 
the juice is extracted from whole fruits then the extracts 
may also contain significant amounts of polyphenols 
derived from the fruit‘s rind and seeds, including 
punicalagins. However, the percentage of these 
components may vary according to the fruit‘s variety, 
storage methods and length, and degree of ripeness.27 
Among plants, flavonoids are the most widely 
distributed polyphenolic compound and are considered 
good antimicrobial agents due to their ability to inactivate 
efflux pumps in microbial cytoplasmic membranes, 
leading to cell lysis and death.25,28 Phenolic compounds 
also inhibit and inactivate the bacterial enzymes required 
for protein biosynthesis.29 One study found that it could 
inhibit nucleic acid biosynthesis and bacteria‘s energy 
metabolisms, thus suggesting an explanation for their 
broad range of antimicrobial effects against Gram-positive 
and Gram-negative bacteria.30 Pomegranate juice‘s 
antibacterial effects may also be related to the presence of 
hydrolyzed tannins and polyphenols, especially 
punicalagin and gallagic acid.31,32 Tannins, in both 
hydrolysable or condensed forms, are water-soluble, 
bioactive polyphenol compounds that exhibit both 
bacteriostatic and bactericidal effects against bacteria due 
to their ability to chelate the metal ions required in 
bacteria‘s biosynthesis of nucleic acids.33 It has also been 
reported that punicalagin (a major component of the 
ellagitannin compound found in pomegranate juice) has an 
antibacterial effect;34 these ellagitannin compounds result 
in turn from the hydrolysis of tannin compounds.35 Ellagic 
acids are considered toxic to bacteria due to their ability to 
disrupt bacterial membranes, potentially leading to 
bacterial cell lysis.36 This would seem to indicate that the 
presence of ellagic acid in pomegranate juice is related to 
the present study‘s finding that pomegranate juice inhibits 
the viability of monospecies and multispecies P. 
gingivalis, A. actinomycetemcomitans, and T. denticola 
biofilms. 
Our results also indicated that the multispecies 
cultures were more significantly inhibited by the 
pomegranate juice than the monospecies cultures. A 
potential explanation for this result is that the different 
metabolic states provided by each strain of bacteria inside 
the biofilm, combined with the limited nutrients available 
and the presence of antimicrobial agents, suppressed 
bacterial growth and thus the formation of multispecies 
biofilms.22 We also noted that the most effective 
concentration of pomegranate juice was different for each 
bacterial strain. Since we used crude extracts of 
pomegranate juice in this study, the extracts may have 
contained many soluble and non-soluble impurities. These 
impurities, especially the non-soluble and half-soluble 
particles, could lead to false positive37 or negative results. 
Further studies should therefore take care to use dilution to 
reduce impurities from samples.38 
Pomegranate (Punica granatum) juice has 
antibacterial effects against the biofilm development of P. 
gingivalis, T. denticola, and A. actinomycetemcomitans, in 
both monospecies and multispecies cultures. Pomegranate 
juice might therefore be used as an alternative 
antibacterial agent for periodontal pathogens, although 
additional research is needed to analyze pomegranate 
juice‘s active component mechanisms.  
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